Skip to content

Re-evaluation of the ice application method in the management of puncture pain for totally implantable venous access ports: A report of research results based on different intervention durations

Re-evaluation of the ice application method in the management of puncture pain for totally implantable venous access ports: A report of research results based on different intervention durations

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114056
Enrollment
Unknown
Registered
2025-12-05
Start date
2025-12-20
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Experimental Group A:After applying ice packs for 1 to 5 minutes, perform puncture at the infusion port
Experimental Group B:After applying ice packs for 5 to 10 minutes, perform puncture at the infusion port
Experimental Group C:After applying ice packs for 10 to 15 minutes, perform puncture at the infusion port
Control group:Before the puncture, offer verbal comfort and gently press the puncture site

Sponsors

The First Affiliated Hospital of Air Force Medical University of the People's Liberation Army of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1)Over 18 years old; (2)Implant and use the infusion port for drug delivery; (3)Have the abilities of listening, speaking, reading and writing; (4)Informed consent to participate in this study;

Exclusion criteria

Exclusion criteria: (1) There is pain in the body or a history of chronic pain (such as recent surgical history, long-term use of painkillers); (2) Reduced skin sensitivity, loss or abnormal sensation (such as Raynaud's syndrome, obliterans, hemiplegia, etc.); (3) Patients with thrombosis confirmed by imaging examinations; (4) Pain-sensitive individuals with a PSQ score greater than 6 points; (5) Patients with clearly diagnosed neurological diseases, blood system diseases, heart system diseases and immune system deficiencies; (6) There is infection, damage or unhealed incision at the injection site.; (7) Allergic to cold (such as urticaria); (8) Avoid using cold food (such as taking medicine, etc.).

Design outcomes

Primary

MeasureTime frame
pain;

Secondary

MeasureTime frame
Blood pressure;Heart rate;Mean Arterial Pressure;Duration of pain;

Countries

China

Contacts

Public ContactXiangying Feng

The First Affiliated Hospital of Air Force Medical University of the People's Liberation Army of China

fengxiangying@126.com+86 139 9192 8695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026